Authors Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S
PloS one Jul 2012
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.Authors Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, Bahadoran P, Rocchi S, Ballotti R, Bertolotto C
The Journal of biological chemistry Jul 2012
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.Authors Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R
Oncogene May 2012
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.Authors Tomic T, Botton T, Cerezo M, Robert G, Luciano F, Puissant A, Gounon P, Allegra M, Bertolotto C, Bereder JM, Tartare-Deckert S, Bahadoran P, Auberger P, Ballotti R, Rocchi S
Cell death & disease Sep 2011
BRCA1 is a new MITF target gene.Authors Beuret L, Ohanna M, Strub T, Allegra M, Davidson I, Bertolotto C, Ballotti R
Pigment cell & melanoma research Aug 2011
Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).Authors Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J, Bille K, Robert C, Bressac-de Paillerets B, Hofman P, Rocchi S, Peyron JF, Lacour JP, Ballotti R, Bertolotto C
Genes & development Jun 2011
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.Authors Fenouille N, Puissant A, Tichet M, Zimniak G, Abbe P, Mallavialle A, Rocchi S, Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S
Oncogene Jun 2011
Advances in melanoma senescence and potential clinical application.Authors Giuliano S, Ohanna M, Ballotti R, Bertolotto C
Pigment cell & melanoma research Apr 2011
Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle.Authors Ohanna M, Bertolotto C, Ballotti R
Pigment cell & melanoma research Feb 2011
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.Authors Fenouille N, Puissant A, Dufies M, Robert G, Jacquel A, Ohanna M, Deckert M, Pasquet JM, Mahon FX, Cassuto JP, Raynaud S, Tartare-Deckert S, Auberger P
Cancer research Dec 2010